The Effect of Bright Light Treatment on Rest-Activity Rhythms in People with Dementia: A 24-Week Cluster Randomized Controlled Trial

被引:5
|
作者
Kolberg, Eirin [1 ]
Pallesen, Stale [2 ,3 ,4 ]
Hjetland, Gunnhild Johnsen [1 ,5 ]
Nordhus, Inger Hilde [1 ,6 ]
Flo-Groeneboom, Elisabeth [1 ]
机构
[1] Univ Bergen UiB, Fac Psychol, Dept Clin Psychol, N-5009 Bergen, Norway
[2] Univ Bergen UiB, Fac Psychol, Dept Psychosocial Sci, N-5015 Bergen, Norway
[3] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway
[4] North West Univ, Optentia, Vaal Triangle Campus, ZA-1911 Vanderbijlpark, South Africa
[5] City Dept Hlth & Care, N-5007 Bergen, Norway
[6] Univ Oslo UiO, Fac Med, Dept Behav Med, N-0372 Oslo, Norway
来源
CLOCKS & SLEEP | 2021年 / 3卷 / 03期
关键词
dementia; nursing homes; bright light therapy; rest-activity rhythms; actigraphy; circadian rhythms; clinical trial; CIRCADIAN ACTIVITY RHYTHMS; NURSING-HOME RESIDENTS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; INSTITUTIONALIZED PATIENTS; MELATONIN SECRETION; SLEEP; EXPOSURE; DISTURBANCES; INTERVENTION;
D O I
10.3390/clockssleep3030032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bright light treatment is an effective way to influence circadian rhythms in healthy adults, but previous research with dementia patients has yielded mixed results. The present study presents a primary outcome of the DEM.LIGHT trial, a 24-week randomized controlled trial conducted at nursing homes in Bergen, Norway, investigating the effects of a bright light intervention. The intervention consisted of ceiling-mounted LED panels providing varying illuminance and correlated color temperature throughout the day, with a peak of 1000 lx, 6000 K between 10 a.m. and 3 p.m. Activity was recorded using actigraphs at baseline and after 8, 16, and 24 weeks. Non-parametric indicators and extended cosine models were used to investigate rest-activity rhythms, and outcomes were analyzed with multi-level regression models. Sixty-one patients with severe dementia (median MMSE = 4) were included. After 16 weeks, the acrophase was advanced from baseline in the intervention group compared to the control group (B = -1.02, 95%; CI = -2.00, -0.05). There was no significant difference between the groups on any other rest-activity measures. When comparing parametric and non-parametric indicators of rest-activity rhythms, 25 out of 35 comparisons were significantly correlated. The present results indicate that ambient bright light treatment did not improve rest-activity rhythms for people with dementia.
引用
收藏
页码:449 / 464
页数:16
相关论文
共 50 条
  • [11] Rest-activity rhythms following digital cognitive behavioural therapy for insomnia: a randomised controlled trial
    Sharman, R.
    Omlin, X.
    Schneider, J.
    Tse, K. Y. K.
    Maurer, L.
    Espie, C. A.
    Kyle, S. D.
    JOURNAL OF SLEEP RESEARCH, 2022, 31
  • [12] Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease
    Dowling, GA
    Hubbard, EM
    Mastick, J
    Luxenberg, JS
    Burr, RL
    Van Someren, EJW
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 (02) : 221 - 236
  • [13] Effects of light supplementation on mood, alertness and rest-activity rhythms in older people living in care homes
    Morgan, P. L.
    Hopkins, S.
    Schlangen, L. J. M.
    Skene, D. J.
    Middleton, B.
    JOURNAL OF SLEEP RESEARCH, 2012, 21 : 370 - 371
  • [14] A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia
    Farlow, Martin R.
    Grossberg, George T.
    Sadowsky, Carl H.
    Meng, Xiangyi
    Somogyi, Monique
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (10) : 745 - 752
  • [15] Bright light therapy: Improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods
    Van Someren, EJW
    Swaab, DF
    Colenda, CC
    Cohen, W
    McCall, WV
    Rosenquist, PB
    CHRONOBIOLOGY INTERNATIONAL, 1999, 16 (04) : 505 - 518
  • [16] Multistrain Probiotics and Telomere Length in Type 2 Diabetes: A 24-Week Randomized Controlled Trial
    Chaithanya, Venkata
    Kumar, Janardanan
    Leela, Kakithakara Vajravelu
    Baig, Habeeb Ali
    Soliman, Mohamed
    Alenezy, Awwad
    Shalaby, Naglaa M.
    LIFE-BASEL, 2025, 15 (02):
  • [17] A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease
    van Dyck, Christopher H.
    Tariot, Pierre N.
    Meyers, Barnett
    Resnick, E. Malca
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (02): : 136 - 143
  • [18] Multisensory stimulation for elderly with dementia: A 24-week single-blind randomized controlled pilot study
    Leszcz, Molyn
    INTERNATIONAL JOURNAL OF GROUP PSYCHOTHERAPY, 2011, 61 (01) : 153 - 158
  • [19] Multisensory stimulation for elderly with dementia: A 24-week single-blind randomized controlled pilot study
    Milev, Roumen V.
    Kellar, Tracey
    McLean, Marilyn
    Mileva, Vick
    Luthra, Veb
    Thompson, Shiela
    Peever, Linda
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2008, 23 (04): : 372 - 376
  • [20] Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis
    Meadowcroft, Amy M.
    Cizman, Borut
    Holdstock, Louis
    Biswas, Nandita
    Johnson, Brendan M.
    Joness, Delyth
    Nossuli, A. Kaldun
    Lepore, John J.
    Aarup, Michael
    Cobitz, Alexander R.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (01) : 139 - 148